SCHEMBL6121651

SCHEMBL6121651

CC(=O)N1CCC(C(=O)N2CCNCC2)CC1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CHRNB2 P17787 2/20 0.71
▸ CHRNA3 P32297 2/20 0.71
▸ CHRNA4 P43681 2/20 0.71
▸ CHRNB3 Q05901 1/20 0.71
▸ CHRNA6 Q15825 1/20 0.71
▸ SMN1; SMN2 Q16637 2/20 0.45
▸ ALDH1A1 P00352 2/20 0.44
▸ HPGD P15428 2/20 0.44
▸ TSHR P16473 2/20 0.44
▸ KMT2A Q03164 1/20 0.40
▸ RIPK1 Q13546 2/20 0.40
▸ NAMPT P43490 1/20 0.40
▸ RECQL P46063 1/20 0.40
▸ HTT P42858 1/20 0.40
▸ CA12 O43570 1/20 0.39
▸ CA1 P00915 1/20 0.39
▸ CA2 P00918 1/20 0.39
▸ CA9 Q16790 1/20 0.39
▸ LMNA P02545 1/20 0.39
▸ CHRNB4 P30926 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27109077 0.86 CHRNB2 (0.80) CHRNB2CHRNA3CHRNA4CHRNB3CHRNA6
SCHEMBL8314 0.84 CHRNB2 (1.00) CHRNB2CHRNA3CHRNA4CHRNB3CHRNA6
SCHEMBL15305154 0.83 CHRNB2 (0.81) CHRNB2CHRNA3CHRNA4CHRNB3CHRNA6
SCHEMBL1241647 0.83 CHRNB2 (0.74) CHRNB2CHRNA3CHRNA4CHRNB3CHRNA6
SCHEMBL13629811 0.82 SMN1; SMN2 (0.49) CHRNB2CHRNA3CHRNA4CHRNB3CHRNA6
SCHEMBL18415366 0.82 HPGD (0.65) CHRNB2CHRNA3CHRNA4CHRNB3CHRNA6
SCHEMBL1706180 0.82 CHRNB2 (0.87) CHRNB2CHRNA3CHRNA4CHRNB3CHRNA6
Piperazine SCHEMBL28221523 0.82 CHRNB2 (0.95) CHRNB2CHRNA3CHRNA4CHRNB3CHRNA6
Hydrochloric Acid SCHEMBL1018088 0.82 CHRNB2 (0.95) CHRNB2CHRNA3CHRNA4CHRNB3CHRNA6
SCHEMBL5433 0.82 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2640698-A1 NAMPT AND ROCK INHIBITORS AbbVie Inc. (US) 2013-09-25 — — EP claimed
WO-2012067965-A1 NAMPT AND ROCK INHIBITORS ABBOTT LABORATORIES (US) 2012-05-24 — — WO claimed
EP-2640698-A1 NAMPT AND ROCK INHIBITORS AbbVie Inc. (US) 2013-09-25 — — EP disclosed
WO-2012067965-A1 NAMPT AND ROCK INHIBITORS ABBOTT LABORATORIES (US) 2012-05-24 — — WO disclosed
Send feedback